TABLE 3.
Acute AOSD | Remission AOSD | HC | p value | |
---|---|---|---|---|
Cytokines | (n = 27) | (n = 11) | (n = 16) | */** |
IL‐4 (pg/ml) | 13.1 ± 6.1 | 8.7 ± 2.1 | 8.5 ± 2.0 | 0.102/0.033 |
IL‐6 (pg/ml) | 109.7 ± 139.4 | 11.7 ± 20.3 | 1.7 ± 0.6 | 0.005/<0.0001 |
IL‐12 (pg/ml) | 1.5 ± 0.5 | 1.8 ± 1.0 | 0.7 ± 0.2 | 0.726/<0.0001 |
IL‐17 (pg/ml) | 32.3 ± 17.6 | 23.3 ± 2.8 | 21.5 ± 4.1 | 0.368/0.025 |
IL‐18 (pg/ml) | 2039.4 ± 779.6 | 351.6 ± 286.6 | 72.0 ± 11.1 | <0.0001/<0.0001 |
IL‐21 (pg/ml) | 26.6 ± 41.2 | 8.4 ± 1.5 | 9.2 ± 1.8 | <0.0001/<0.0001 |
IFN‐γ (pg/ml) | 75.3 ± 167.3 | 3.3 ± 2.0 | 2.3 ± 3.2 | <0.0001/<0.0001 |
Data are presented as the mean ± standard deviation (SD).
Abbreviations: HC, healthy controls; IL, interleukin; IFN‐γ, interferon‐γ.
Comparisons between acute and remission phases in 11 acute adult‐onset Still’s disease (AOSD) patients using Wilcoxon’s signed‐rank test.
Comparisons between 27 acute AOSD patients and 16 HC using the Mann–Whitney U‐test. A p value less than 0.05 was considered statistically significant.